Trials / Recruiting
RecruitingNCT05856370
The Ailliance Post-Market Clinical Study
The Ailliance Post-Market Clinical Study: All enablIng technoLogies, bioLogics, IDS, And Core spiNe produCt collEction
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,000 (estimated)
- Sponsor
- Medtronic Spinal and Biologics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical study is to collect performance and safety data for post-market Medtronic devices indicated for cranial and/or spinal indication(s). Subjects are enrolled and followed postoperatively to 24 months. The Ailliance clinical study is intended to collect data congruous with routine clinical care practices.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Follow-up schedule: pre-operative baseline up to 24-months post-procedure | Follow-up assessments will be required (therefore interventional) from pre-operative baseline to 24 months post index surgery |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2031-05-01
- Completion
- 2031-05-01
- First posted
- 2023-05-12
- Last updated
- 2026-02-04
Locations
24 sites across 4 countries: United States, France, Spain, United Kingdom
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05856370. Inclusion in this directory is not an endorsement.